These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 6778386)

  • 1. Synthesis of 3-O-demethylfortimicins.
    Martin JR; Johnson P; Tadanier J; Goldstein A
    Antimicrob Agents Chemother; 1980 Nov; 18(5):761-5. PubMed ID: 6778386
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chemical modification of fortimicins: preparation of 4-N-substituted fortimicin B.
    Sato M; Mori Y
    J Antibiot (Tokyo); 1979 Apr; 32(4):371-8. PubMed ID: 468724
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative antimicrobial activity of O-demethylfortimicin A, a derivative of fortimicin A.
    Girolami RL; Stamm JM
    Antimicrob Agents Chemother; 1980 Nov; 18(5):766-72. PubMed ID: 7447430
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The in-vitro activity of O-demethylfortimicin.
    Neu HC
    J Antimicrob Chemother; 1983 Feb; 11(2):181-5. PubMed ID: 6833173
    [TBL] [Abstract][Full Text] [Related]  

  • 5. synthesis of 2-deoxyfortimicins and 1-deamino-2-deoxy-2-epi-aminofortimicins via 2-O-methanesulfonylfortimicin B.
    Martin JR; Johnson P; Tadanier J; Goldstein AW
    J Antibiot (Tokyo); 1980 Aug; 33(8):810-8. PubMed ID: 7429983
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 4-N-acylfortimicins B and the preparation of fortimicin A from fortimicin B.
    Tadanier J; Martin JR; Kurath P; Goldstein AW; Johnson P
    Carbohydr Res; 1980 Feb; 79(1):91-102. PubMed ID: 7357570
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 3-O-demethyl-2,3-di-epi-fortimicins and 3-O-demethyl-3-epi-fortimicins.
    Tadanier J; Hallas R
    J Antibiot (Tokyo); 1983 Mar; 36(3):256-66. PubMed ID: 6833145
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Compound A49759, the 3-O-demethyl derivative of fortimicin A: in vitro comparison with six other aminoglycoside antibiotics.
    Jones RN; Thornsberry C; Barry AL; Packer RR; Baker CN; Badal RE
    Antimicrob Agents Chemother; 1980 Nov; 18(5):773-9. PubMed ID: 7447431
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fortimicins A and B, new aminoglycoside antibiotics. IV. In vitro study of fortimicin A compared with other aminoglycosides.
    Girolami RL; Stamm JM
    J Antibiot (Tokyo); 1977 Jul; 30(7):564-70. PubMed ID: 19409
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chemical modification of fortimicins. III. preparation of N-substituted fortimicin A derivatives.
    Mochida K; Sato M; Yoshiie S; Mori Y; Shirahata K; Kitaura K
    J Antibiot (Tokyo); 1981 May; 34(5):522-9. PubMed ID: 7275834
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diastereomeric fortimicin 1,2-epoxides. The preparation of the 1-deamino-2-deoxyfortimicins A and B and the 1,2-di-epi-fortimicins A and B.
    Martin JR; Johnson P; Tadanier J; Cirovic M; Stanaszek RS
    J Antibiot (Tokyo); 1982 Jan; 35(1):46-57. PubMed ID: 7068515
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis and antibacterial activity of 1-N-[(S)-ω-amino-2-hydroxyalkyl] derivatives of dibekacin, 5-deoxydibekacin, 3'-deoxykanamycin A and gentamicin B.
    Umemura E; Sakamoto Y; Takahashi Y; Miyake T
    J Antibiot (Tokyo); 2015 Jun; 68(6):421-3. PubMed ID: 25712399
    [No Abstract]   [Full Text] [Related]  

  • 13. 4-N-(2-aminoethanesulfonyl)fortimicin B and 4-N-(p-aminobenzenesulfonyl)fortimicin B.
    Tadanier J; Hallas R
    J Antibiot (Tokyo); 1981 Apr; 34(4):403-11. PubMed ID: 7275819
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chemical modification of fortimicins. IV. Preparation of 4,2'-Di-N-substituted fortimicin B derivatives.
    Sato M; Mochida K; Yoshiie S; Mori Y; Shirahata K; Kitaura K
    J Antibiot (Tokyo); 1981 May; 34(5):530-5. PubMed ID: 7275835
    [No Abstract]   [Full Text] [Related]  

  • 15. 3-amino-3-demethoxyfortimicin A and the C-2 epimeric-2-amino-3-O-demethyl-2-deoxyfortimicins A.
    Tadanier J; Hallas R; Holms J; Freiberg LA; Bacino D
    J Antibiot (Tokyo); 1983 Mar; 36(3):267-75. PubMed ID: 6833146
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dimeric aminoglycosides as antibiotics.
    Agnelli F; Sucheck SJ; Marby KA; Rabuka D; Yao SL; Sears PS; Liang FS; Wong CH
    Angew Chem Int Ed Engl; 2004 Mar; 43(12):1562-6. PubMed ID: 15022234
    [No Abstract]   [Full Text] [Related]  

  • 17. Synergistic activities of fortimicin A and beta-lactam antibiotics against Pseudomonas aeruginosa.
    Yamashita K; Kawabe H; Mitsuhashi S
    Antimicrob Agents Chemother; 1981 Jul; 20(1):33-7. PubMed ID: 6792980
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Substances derived from 4-de-N-methylfortimicin B.
    Kurath P; Tadanier J; Johnson P; Grampovnik D; Egan RS; Stanaszek RS; Cirovic M; Washburn WH; Leonard JE
    J Antibiot (Tokyo); 1981 Jun; 34(6):691-700. PubMed ID: 7275853
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The base catalyzed rearrangement of 3-O-demethylfortimicin A.
    Lartey PA; Grampovnik DJ
    J Antibiot (Tokyo); 1980 Sep; 33(9):1071-3. PubMed ID: 7440411
    [No Abstract]   [Full Text] [Related]  

  • 20. Discovery of 2-hydroxyarbekacin, a new aminoglycoside antibiotic with reduced nephrotoxicity.
    Takahashi Y; Umemura E; Kobayashi Y; Murakami S; Nawa T; Morinaka A; Miyake T; Shibasaki M
    J Antibiot (Tokyo); 2018 Feb; 71(2):345-347. PubMed ID: 28655929
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.